Cadrenal Therapeutics
CVKD
#9770
Rank
ยฃ25.67 M
Marketcap
ยฃ13.66
Share price
-4.50%
Change (1 day)
85.62%
Change (1 year)

Revenue for Cadrenal Therapeutics (CVKD)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cadrenal Therapeutics from 2023 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A